Hunan Hansen Pharmaceutical Co. Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000PK2
CNY
7.19
0.17 (2.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,026.82
992.66
943.95
905.27
881.46
733.75
875.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,026.82
992.66
943.95
905.27
881.46
733.75
875.81
Raw Material Cost
249.49
256.56
272.55
272.23
263.23
237.59
250.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
213.58
178.99
167.27
137.59
134.12
108.85
126.51
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.95
2.87
3.89
4.11
6.85
7.44
10.32
Selling and Distribution Expenses
500.96
456.07
451.77
444.50
444.39
371.86
398.13
Other Expenses
-17.78
-14.39
-12.88
-9.38
-10.15
-8.51
-10.34
Total Expenditure (Excl Depreciation)
788.15
750.61
766.70
764.64
747.07
640.68
681.77
Operating Profit (PBDIT) excl Other Income
238.70000000000002
242.10000000000002
177.2
140.6
134.4
93.10000000000001
194
Other Income
8.94
9.68
9.59
1.73
4.04
11.62
9.92
Operating Profit (PBDIT)
278.96
287.70
231.12
187.24
182.04
148.17
246.38
Interest
1.95
2.87
3.89
4.11
6.85
7.44
10.32
Exceptional Items
1.85
2.07
-7.28
-39.50
-40.42
-25.85
-46.12
Gross Profit (PBDT)
777.34
736.11
671.40
633.04
618.23
496.15
625.61
Depreciation
41.51
41.48
51.68
52.30
51.70
50.61
48.32
Profit Before Tax
237.34
245.42
168.27
91.32
83.06
64.27
141.62
Tax
40.49
32.51
21.00
14.24
15.05
11.49
26.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
198.12
220.24
205.01
167.62
134.85
106.15
162.38
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
198.12
220.24
205.01
167.62
134.85
106.15
162.38
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
198.12
220.24
205.01
167.62
134.85
106.15
162.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,380.92
2,203.38
1,963.03
1,894.13
1,742.29
1,594.72
1,529.98
Earnings per share (EPS)
0.39
0.44
0.41
0.33
0.27
0.21
0.32
Diluted Earnings per share
0.39
0.44
0.41
0.33
0.27
0.21
0.32
Operating Profit Margin (Excl OI)
22.25%
23.83%
17.99%
14.71%
14.33%
11.71%
21.48%
Gross Profit Margin
27.16%
28.9%
23.3%
15.87%
15.29%
15.66%
21.69%
PAT Margin
19.29%
22.19%
21.72%
18.52%
15.3%
14.47%
18.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 3.44% vs 5.17% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -10.04% vs 7.41% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -2.88% vs 25.51% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -31.03% vs -25.64% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Hunan Hansen Pharmaceutical Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,026.82
0
1,026.82
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,026.82
0
1,026.82
Raw Material Cost
249.49
0
249.49
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
213.58
0
213.58
Power Cost
0
0
0.00
Manufacturing Expenses
1.95
0
1.95
Selling and Distribution Expenses
500.96
0
500.96
Other Expenses
-17.78
0.00
-17.78
Total Expenditure (Excl Depreciation)
788.15
0
788.15
Operating Profit (PBDIT) excl Other Income
238.68
0.00
238.68
Other Income
8.94
0
8.94
Operating Profit (PBDIT)
278.96
0
278.96
Interest
1.95
0
1.95
Exceptional Items
1.85
0
1.85
Gross Profit (PBDT)
777.34
0
777.34
Depreciation
41.51
0
41.51
Profit Before Tax
237.34
0
237.34
Tax
40.49
0
40.49
Provisions and contingencies
0
0
0.00
Profit After Tax
198.12
0
198.12
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
198.12
0
198.12
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
198.12
0
198.12
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,380.92
0
2,380.92
Earnings per share (EPS)
0.39
0
0.39
Diluted Earnings per share
0.39
0
0.39
Operating Profit Margin (Excl OI)
22.25%
0%
0.00
22.25%
Gross Profit Margin
27.16%
0%
0.00
27.16%
PAT Margin
19.29%
0%
0.00
19.29%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 102.68 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 3.44% vs 5.17% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 19.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -10.04% vs 7.41% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 27.00 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -2.88% vs 25.51% in Dec 2024

Annual - Interest
Interest 0.20 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -31.03% vs -25.64% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.25%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024